Exos Asset Management’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-78,095
Closed -$3.12K 26
2024
Q4
$3.12K Hold
78,095
0.72% 26
2024
Q3
$4.69K Sell
78,095
-78,095
-50% -$6.51K 0.45% 31
2024
Q2
$11.3K Buy
156,190
+25,949
+20% +$2.6K 0.01% 88
2024
Q1
$18.7K Buy
+130,241
New +$22K 0.01% 115
2022
Q2
Sell
-57,018
Closed -$40K 308
2022
Q1
$40K Hold
57,018
0.02% 262
2021
Q4
$43K Hold
57,018
0.02% 297
2021
Q3
$60K Buy
+57,018
New +$68.7K 0.03% 323

Other funds holding XAGEW

Exos Asset Management's XAGEW Position: Q1 2025 in Review

Exos Asset Management sold out of Longevity Health Holdings, Inc. Warrant (XAGEW) in Q1 2025, closing a stake of 78,095 shares — an estimated $3.12K sold.

Exos Asset Management first reported a position in XAGEW in Q3 2021 and held it in 7 quarters. The position peaked at $60K in Q3 2021. 12 funds tracked by Wall St. Rank hold XAGEW as of Q1 2025.

  • Exos Asset Management reported no remaining Longevity Health Holdings, Inc. Warrant position as of Q1 2025 after selling out during the quarter.
  • Exos Asset Management sold 78,095 Longevity Health Holdings, Inc. Warrant shares in Q1 2025, an estimated $3.12K.
  • Exos Asset Management first reported a position in Longevity Health Holdings, Inc. Warrant in Q3 2021 and held it in 7 quarters.
  • Exos Asset Management's Longevity Health Holdings, Inc. Warrant position peaked at $60K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q1 2025.

Based on Exos Asset Management's 13F filing for Q1 2025, filed 15 May 2025.